Trials / Unknown
UnknownNCT02642198
Non-Invasive Blood Pressure Monitor Accuracy in Neonatal Subjects
Clinical Investigation for Non-invasive Blood Pressure Monitor Accuracy Validation Performed on Neonatal, Infants and Children up to 3 Years Old
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 25 (estimated)
- Sponsor
- Mortara Instrument · Industry
- Sex
- All
- Age
- 29 Days – 3 Years
- Healthy volunteers
- Accepted
Summary
This study is being conducted to validate the accuracy of non-invasive blood pressure (NIBP) measurement technology from Mortara Instrument, Inc. (Milwaukee, Wisconsin, USA) and Zoe Medical, Inc. (Topsfield, Massachusetts, USA) in a neonatal, infants and children up to 3 years old patient population. The study is defined according to the International Standard "ANSI/AAMI/ISO 81060-2:2013, Non-invasive sphygmomanometers - Part 2: Clinical investigation of automated measurement type".
Detailed description
The device under test is Mortara Instrument's Surveyor S12/S19 patient monitors ("Surveyor") incorporating neonatal NIBP technology. Specifically, NIBP measurements will be taken using a cuff on the patient's limb (exact location will be determined by clinician) using a variety of cuffs sized for neonates and pediatrics. The device utilizes oscillometric technology to obtain quickly and conveniently non-invasive blood pressure measurements. Results will be compared to invasive blood pressure measurements from patients already monitored with such sensors. The Device under Test will be calibrated and verified by a Mortara representative on site.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Surveyor S12 and S19 patient monitor | Non-invasive blood pressure measurement |
Timeline
- Start date
- 2015-10-01
- Primary completion
- 2016-03-01
- First posted
- 2015-12-30
- Last updated
- 2016-03-23
Locations
2 sites across 1 country: Italy
Source: ClinicalTrials.gov record NCT02642198. Inclusion in this directory is not an endorsement.